Last deal

$11.3M

Amount

Venture - Series Unknown

Stage

30.04.2007

Date

2

all rounds

$20.8M

Total amount

General

About Company
Nautilus Biotech is a biotechnology company that develops and sells therapeutic proteins with improved profiles.

Industry

Sector :

Subsector :

founded date

01.01.1999

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's products include Belerofon, an injectable and orally available interferon alpha for treating chronic Hepatitis C infection, and Vitatropin, an injectable and orally available human growth hormone for treating growth deficiencies. Nautilus Biotech uses protein engineering technology to enhance the pharmacology profile and administration route of popular protein drugs. Founded in 1999 and based in Evry, France, the company sells its products in France and internationally.